The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C09 | Agents acting on the renin-angiotensin system | |
| 3 | C09D | Angiotensin II antagonists, combinations | |
| 4 | C09DA | Angiotensin II antagonists and diuretics | |
| 5 | C09DA01 | Losartan and diuretics |
| Title | Information Source | Document Type | |
|---|---|---|---|
| FORTZAAR Tablet | Health Products Regulatory Authority (ZA) | MPI, Generic | |
| HYZAAR Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| LOSARB PLUS Film-coated tablet | MPI, EU: PIL |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
